内容简介：
【简介】 To realize the vast potential of tissue engineering and other techniques aimed at repairing damaged or diseased tissues and organs, the University of Pittsburgh School of Medicine and UPMC Health System have established the McGowan Institute for Regenerative Medicine. The McGowan Institute serves as a single base of operations for the university's leading scientists and clinical faculty working to develop tissue engineering, cellular therapies, biosurgery and artificial and biohybrid organ devices.
The Institute mission includes the development of innovative clinical protocols as well as the pursuit of rapid commercial transfer of its technologies related to regenerative medicine. Regenerative medicine is an emerging field that approaches the repair or replacement of tissues and organs by incorporating the use of cells, genes or other biological building blocks along with bioengineered materials and technologies.
The McGowan Institute Director is Alan J. Russell, Ph.D., who until accepting this assignment served as the Nikolas DeCecco Professor and Chairman of Chemical and Petroleum Engineering at the University of Pittsburgh School of Engineering, and the Associate Director of the University's Center for Biotechnology and Bioengineering. He also serves as the Executive Director of the Pittsburgh Tissue Engineering Initiative.
The Institute takes its name from the McGowan Center for Artificial Organ Development, which has been incorporated into the McGowan Institute. Through the McGowan Institute's expanded role and mission, other university faculty have joined forces to address promising opportunities in tissue engineering, adult-derived stem cell research and wound healing.
